IL-23 induces CLEC5A+ IL-17A+ neutrophils and elicit skin inflammation associated with psoriatic arthritis
Hiroki Furuya,Cuong Thach Nguyen,Trevor Chan,Alina I Marusina,Alexander A Merleev,Maria de la Luz Garcia-Hernandez,Shie-Liang Hsieh,George C Tsokos,Christopher T Ritchlin,Ilias Tagkopoulos,Emanual Maverakis,Iannis E Adamopoulos,Alina I. Marusina,Alexander A. Merleev,George C. Tsokos,Christopher T. Ritchlin,Iannis E. Adamopoulos
DOI: https://doi.org/10.1016/j.jaut.2024.103167
IF: 14.511
2024-02-01
Journal of Autoimmunity
Abstract:IL-23-activation of IL-17 producing T cells is involved in many rheumatic diseases. Herein, we investigate the role of IL-23 in the activation of myeloid cell subsets that contribute to skin inflammation in mice and man. IL-23 gene transfer in WT, IL-23R<sup>GFP</sup> reporter mice and subsequent analysis with spectral cytometry show that IL-23 regulates early innate immune events by inducing the expansion of a myeloid MDL1<sup>+</sup>CD11b<sup>+</sup>Ly6G<sup>+</sup> population that dictates epidermal hyperplasia, acanthosis, and parakeratosis; hallmark pathologic features of psoriasis. Genetic ablation of MDL-1, a major PU.1 transcriptional target during myeloid differentiation exclusively expressed in myeloid cells, completely prevents IL-23-pathology. Moreover, we show that IL-23-induced myeloid subsets are also capable of producing IL-17A and IL-23R<sup>+</sup>MDL1<sup>+</sup> cells are present in the involved skin of psoriasis patients and gene expression correlations between IL-23 and MDL-1 have been validated in multiple patient cohorts. Collectively, our data demonstrate a novel role of IL-23 in MDL-1-myelopoiesis that is responsible for skin inflammation and related pathologies. Our data open a new avenue of investigations regarding the role of IL-23 in the activation of myeloid immunoreceptors and their role in autoimmunity.
immunology